scispace - formally typeset
A

Anna Gavin

Researcher at Queen's University Belfast

Publications -  269
Citations -  14092

Anna Gavin is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 41, co-authored 254 publications receiving 10074 citations. Previous affiliations of Anna Gavin include Queen's University & Leeds Teaching Hospitals NHS Trust.

Papers
More filters
Journal ArticleDOI

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Claudia Allemani, +594 more
- 17 Mar 2018 - 
TL;DR: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden, while for many cancers, Denmark is closing the survival gap with the other Nordic countries.
Journal ArticleDOI

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

TL;DR: The present estimates of the cancer burden in Europe alongside a description of the profiles of common cancers at the national and regional level provide a basis for establishing priorities for cancer control actions across Europe.
Journal ArticleDOI

International incidence of childhood cancer, 2001-10 a population-based registry study

Eva Steliarova-Foucher, +229 more
- 01 Jun 2017 - 
TL;DR: This unique global source of childhood cancer incidence will be used for aetiological research and to inform public health policy, potentially contributing towards attaining several targets of the Sustainable Development Goals.
Journal ArticleDOI

Risk of Malignant Progression in Barrett’s Esophagus Patients: Results from a Large Population-Based Study

TL;DR: The risk of malignant progression among patients with BE is found to be lower than previously reported, suggesting that currently recommended surveillance strategies may not be cost-effective.
Journal ArticleDOI

Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

TL;DR: Progress in cancer control over the study period was evident for stomach, colon, lung (in males), and ovarian cancer, and the impact of comorbidity are likely the main determinants of patient outcomes.